Skip to content

The Effect of Scalp Acupuncture Combined with Jiaji (Paravertebral) Acupoints and TOT Technology on Children with Cerebral Palsy Complicated by Intellectual Development Disorder

The Effect of Scalp Acupuncture Combined with Jiaji (Paravertebral) Acupoints and TOT Technology on Children with Cerebral Palsy Complicated by Intellectual Development Disorder

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025002378
Enrollment
Unknown
Registered
2025-12-06
Start date
2025-07-10
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral Palsy with Intellectual Disability

Interventions

Treatment Group:Acupuncture Combined with TOT Training
Control Group 1:Simple Acupuncture
Control Group 2:Simple TOT Training

Sponsors

The First Affiliated Hospital of Changsha Medical University (The First Clinical College)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
5 Years to 12 Years

Inclusion criteria

Inclusion criteria: (1) Meeting the above diagnostic criteria for children with cerebral palsy complicated by intellectual developmental disorder.(2) No organic lesions other than the etiological factors of this disease detected in examinations.(3) The child is conscious and has stable vital signs.(4) Aged 5–12 years old.(5) The child and their guardian are willing to cooperate with treatment procedures, examinations, and efficacy assessment.(6) Those who voluntarily participate in this trial have signed the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Not meeting the diagnostic criteria and inclusion criteria.(2) Patients with unstable vital signs or altered consciousness.(3) Patients with severe cardiovascular and cerebrovascular diseases, severe diabetes mellitus, severe infections, severe heart disease, malignant hypertension, hepatic or renal insufficiency, hematopoietic system disorders, mental illness, acquired immunodeficiency syndrome (AIDS), as well as infectious diseases such as hepatitis and tuberculosis.(4) Patients with contraindications to acupuncture and rehabilitation treatment in this trial.(5) Patients who are unwilling to participate in this trial, withdraw voluntarily midway, or fail to complete the trial content.(6) Patients who are unable to cooperate or are currently participating in trials of other treatment methods.

Design outcomes

Primary

MeasureTime frame
Gesell;

Secondary

MeasureTime frame
GAP-43 Nogo-A;

Countries

China

Contacts

Public ContactLeiJingjing

Changsha Medical University

465605118@qq.com18073119993

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026